Systems and methods for non-intrusive drug impairment detection

• US 10,376,183 B2
• Filed: 04/27/2015
• Issued: 08/13/2019
• Est. Priority Date: 04/29/2014
• Status: Active Grant

• Current Assignee: Dignity Health (CommonSpirit Health (Illinois)), Arizona Board of Regents (University of Arizona)
• Original Assignee: Dignity Health (CommonSpirit Health (Illinois))
• Inventors: Macknik, Stephen L., Martinez-Conde, Susana, Dale, Richard E., Besserman, Richard, McDaniel, Tropy
• Primary Examiner(s): Fernandes, Patrick
• Application Number:
  US15/306,892
• Publication Number:
  US 20170049362A1
• Time in Patent Office: 1,569 Days
• CPC Class Codes: A61B 3/113 for determining or recording eye movement
• CPC Class Codes: A61B 5/1104 induced by stimuli or drugs; A61B5/1102 takes precedence; investigating medicinal preparations G01N33/15
• CPC Class Codes: A61B 5/163 by tracking eye movement, gaze, or pupil change
• CPC Class Codes: A61B 5/18 for vehicle drivers or machine operators
• CPC Class Codes: A61B 5/4845 Toxicology, e.g. by detection of alcohol, drug or toxic products A61B5/4848 takes precedence
• CPC Class Codes: A61B 5/746 Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms alarms per se G08B

Abstract

Systems and methods for detecting onset, presence, and progression of particular states, including intoxication, include observing eye movements of a subject and correlating the observed movements to known baseline neurophysiological indicators of intoxication. A detection system may record eye movement data from a user, compare the eye movement data to a data model comprising threshold eye movement data samples, and from the comparison make a determination whether or not intoxication or impairment is present. The detection system may alert the user to take corrective action if onset or presence of a dangerous condition is detected. The eye movements detected include saccadic and intersaccadic parameters such as intersaccadic drift velocity. Measurements may be collected in situ with a field testing device. An interactive application may be provided on a user device to provoke the desired eye movements during recording.

Claims

1. A system, comprising:

a sensing arrangement that collects eye movement data of a user;

an alerting arrangement that produces an perceptible alert in response to receipt of an alert signal; and

a control unit in electronic communication with the sensing arrangement and the alerting arrangement, the control unit comprising;

a data analysis module that configures the control unit to extract one or more current eye movement dynamics, including one or more intersaccadic drift velocities, from the eye movement data; and

a comparison module that configures the control unit to;

receive the one or more current eye movement dynamics from the data analysis module;

identify, by comparing the one or more current eye movement dynamics, including the one or more intersaccadic drift velocities, to one or more baseline eye movement dynamics accessible by the control unit, a neurologic impairment caused by an intoxicated state of the user; and

send the alert signal to the alerting arrangement in response to an identification of the neurologic impairment;

wherein the data analysis module is configured to calculate the one or more intersaccadic drift velocities; and

wherein the comparison module is configured to compare the one or more intersaccadic drift velocities to one or more threshold drift velocities of the one or more baseline eye movement dynamics.

2. The system of claim 1, wherein one of the one or more intersaccadic drift velocities comprises a drift mean velocity, and wherein when the drift mean velocity is slower than the one or more threshold drift velocities by more than a threshold amount, the comparison module sends the alert signal.

3. The system of claim 1, wherein one of the one or more intersaccadic drift velocities comprises a current intersaccadic drift velocity, and wherein when the current intersaccadic drift velocity is slower than the one or more threshold drift velocities by more than a threshold amount, the comparison module sends the alert signal.

4. The system of claim 3, wherein the data analysis module calculates the current intersaccadic drift velocity by:

identifying, in the eye movement data, a drift period comprising a duration and a distance; and

determining the current intersaccadic drift velocity from the duration and the distance.

5. The system of claim 1, wherein the one or more eye movement dynamics include one or more saccade parameters.

6. The system of claim 5, wherein the one or more saccade parameters comprise a saccadic peak velocity and a magnitude.

7. The system of claim 1, further comprising an application presented on a user device for interaction by the user while the eye movement data is collected.

8. The system of claim 1, wherein the intoxicated state identifiable from the one or more baseline eye movement dynamics is a marijuana-induced intoxicated state.

9. The system of claim 1, wherein the one or more baseline measurements comprise one or more bio-signatures of a plurality of substances.

10. The system of claim 9, wherein each of the plurality of substances is a drug.

11. The system of claim 10, wherein one of the plurality of substances associated with one of the biosignatures is marijuana.

12. The system of claim 9, wherein the control unit is configured to compare the eye movement data to one or more baseline measurements of eye movement dynamics by determining whether one or more of the biosignatures is present in the eye movement data.

13. The system of claim 12, wherein the control unit is further configured to, responsive to a determination that a first of the one or more biosignatures is present in the eye movement data, identify one substance of the plurality of substances associated with the first biosignature and include an indication of the one substance in the alert.

14. The system of claim 9, wherein the one or more biosignatures each identify one of a plurality of categories of drugs.

19. The method of claim 13, wherein the eye movement data comprises one or both of saccade parameters and intersaccadic drift parameters.

21. The method of claim 13, further comprising providing to the user a device having an interactive application, wherein the eye movement data is recorded while the user engages with or responds to the interactive application.

15. A system, comprising:

a sensing arrangement that collects eye movement data of a user; and

a control unit in communication with the sensing arrangement, the control unit being configured to;

compare the eye movement data, including a current intersaccadic drift velocity within the eye movement data, to one or more baseline measurements of eye movement dynamics to identify an intoxicated state of the user; and

responsive to a result of the comparison indicating the presence of the intoxicated state, generate an alert for delivery to the user;

wherein the control unit is configured to calculate the current intersaccadic drift velocity; and

wherein the control unit is configured to compare the current intersaccadic drift velocity to one or more threshold drift velocities of the one or more baseline measurements.

16. The system of claim 15, wherein the eye movement data comprises one or more saccade parameters.

17. The system of claim 16, wherein comparing the eye movement data, including the current intersaccadic drift velocity within the eye movement data, to the one or more baseline measurements comprises calculating the current intersaccadic drift velocity of the user from the one or more saccade parameters and comparing the current intersaccadic drift velocity to the one or more threshold drift velocities of the one or more baseline measurements.

18. A method of determining a physiological state of a user, the method comprising:

recording, with a sensing arrangement, from the user eye movement data of one or both of the user'"'"'s eyes;

comparing, with a control unit, the eye movement data to one or more baseline measurements corresponding to an intoxicated state, the comparing comprising;

extracting one or more current eye movement dynamics, including one or more intersaccadic drift velocities, from user eye movement data;

calculating the one or more intersaccadic drift velocities; and

comparing the one or more intersaccadic drift velocities to one or more threshold drift velocities of the one or more baseline measurements; and

if the one or more intersaccadic drift velocities diverge from one or more of the one or more threshold drift velocities by a threshold amount, delivering, by the control unit, an alert indicating the user is in the intoxicated state.

20. The method of claim 18, wherein the intoxicated state identifiable from the one or more baseline measurements is a marijuana-induced intoxicated state.

22. The method of claim 18, further comprising:

recording, with the sensing arrangement, from the user pupil size and bright light stimulus data of one or both of the user'"'"'s eyes; and

correlating, with the control unit, the pupil size and bright light stimulus data to one or more characteristic measurements of the intoxicated state to determine a presence of the intoxicated state.

23. The method of claim 18, wherein the one or more baseline measurements comprise one or more bio-signatures each associated with one of a plurality of substances.

24. The method of claim 23, wherein each of the plurality of substances is a drug.

25. The method of claim 24, wherein one of the plurality of substances associated with one of the bio-signatures is marijuana.

26. The method of claim 24, wherein comparing the eye movement data to one or more baseline measurements corresponding to the intoxicated state comprises determining whether one or more of the bio-signatures is present in the eye movement data.

27. The method of claim 26, wherein comparing the eye movement data to one or more baseline measurements corresponding to an intoxicated state further comprises, responsive to a determination that a first of the one or more bio-signatures is present in the eye movement data, identifying the drug associated with the first of the one or more bio-signatures and including an indication of the drug in the alert.

28. The method of claim 23, wherein the one or more bio-signatures each identify one of a plurality of categories of drugs.

29. A system, comprising:

a sensing arrangement that collects eye movement data of a user; and

a control unit in communication with the sensing arrangement, the control unit being configured to;

calculate, from the eye movement data, one or more intersaccadic drift velocities;

compare the eye movement data, including the one or more intersaccadic drift velocities, to one or more baseline measurements of eye movement dynamics to identify an intoxicated state of the user; and

compare the one or more intersaccadic drift velocities to one or more threshold drift velocities of the one or more baseline measurements of eye movement dynamics

responsive to a result of comparison indicating a presence of the intoxicated state, generate an alert for delivery to the user.

30. The system of claim 29, wherein the one or more intersaccadic drift velocities include a current intersaccadic drift velocity of the user and the one or more baseline measurements include one or more threshold drift velocities.

31. The system of claim 29, wherein the eye movement data comprises one or more saccade parameters and wherein the one or more intersaccadic drift velocities include a current intersaccadic drift velocity of the user from the one or more saccade parameters and the one or more baseline measurements include one or more threshold drift velocities.

32. The system of claim 29, wherein the control unit is configured to compare the eye movement data to one or more baseline measurements of eye movement dynamics by determining whether one or more of bio-signatures is present in the eye movement data.

33. The system of claim 32, wherein the control unit is further configured to, responsive to a determination that a first of the one or more bio:

signatures is present in the eye movement data, identify a drug associated with the first of the one or more bio-signatures and include an indication of the drug in the alert.

34. The system of claim 32, wherein the one or more bio-signatures each identify one of a plurality of categories of drugs.